BrainsWay (NASDAQ:BWAY) Posts Earnings Results, Beats Estimates By $0.05 EPS

BrainsWay (NASDAQ:BWAY) posted its quarterly earnings results on Tuesday. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.05, Zacks reports. BrainsWay had a return on equity of 3.52% and a net margin of 3.88%.

BrainsWay Stock Performance

BrainsWay stock opened at $9.19 on Tuesday. The firm’s fifty day moving average price is $10.21 and its 200-day moving average price is $9.57. BrainsWay has a fifty-two week low of $4.61 and a fifty-two week high of $11.79. The stock has a market cap of $173.02 million, a P/E ratio of 91.91 and a beta of 1.29.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reiterated a “buy” rating and set a $16.00 price target on shares of BrainsWay in a research note on Monday, December 23rd.

BrainsWay Company Profile

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases.